Position in PLRX
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$2,997
+$95 QoQ
Shares Held
2,379
0.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
18 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in PLRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RHUMBLINE ADVISERS holds $1,237,848,251 across 287 Biotechnology names. PLRX ranks #266 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
423,140 | $188,948,935 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,781 | $121,907,911 | |
| 3 | INCY |
Incyte Corp
|
693,665 | $65,287,749 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
195,277 | $64,611,300 | |
| 5 | INSM |
INSMED Inc
|
272,615 | $44,578,004 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
164,542 | $31,106,665 | |
| 7 | EXEL |
Exelixis, Inc.
|
723,931 | $31,049,400 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,113,266 | $30,837,468 |
All Filings in PLRX
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,997 | 2,379 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $2,902 | 2,379 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,520 | 2,379 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $2,759 | 2,379 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $121,086 | 89,694 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $1,219,278 | 92,580 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $1,061,553 | 94,697 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,037,246 | 96,488 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $1,219,207 | 81,826 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,459,919 | 80,614 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $1,371,541 | 79,097 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $1,428,617 | 78,842 | Shares | Sole | 2023-08-08 | |
| 2022-03-31 | $160,297 | 22,867 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $301,644 | 22,344 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $384,188 | 22,760 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $633,796 | 21,765 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $945,768 | 24,047 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $232,857 | 10,249 | Shares | Sole | 2021-02-10 | |
| No filing history on record for this holder in this stock. | ||||||